Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis
2004
Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.
2003
From traditional Chinese medicine to rational cancer therapy
2007 Standout
Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1
2006 Standout
CLINICAL STUDIES OF CAMPTOTHECIN AND DERIVATIVES
2003
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin
2003
Clinical translation of angiogenesis inhibitors
2002 Standout
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
2004
Organocatalytic cascade reactions as a new tool in total synthesis
2010 Standout
3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice
2005
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Preparation of Large Monodisperse Vesicles
2009 StandoutNobel
HYPOXIA AND ANGIOGENESIS IN PANCREATIC CANCER
2006
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Clinical applications of the camptothecins
1998
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
2005
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Angiogenesis and Vascular Functions in Modulation of Obesity, Adipose Metabolism, and Insulin Sensitivity
2013
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Camptothecin and its analogues: a review on their chemotherapeutic potential
2005
9-NITROCAMPTOTHECIN LIPOSOME AEROSOL: LACK OF SUBACUTE TOXICITY IN DOGS
2002
Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma
2002
Topoisomerase I inhibitors: Review and update
1997
What We Talk About When We Talk About Fat
2014 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer
2002
Camptothecins
2002
Cancer of the Ovary
2004 Standout
Gemcitabine Plus Paclitaxel in Breast Cancer
2005
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
2002
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors.
2003
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer
2014
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Molecular Modeling Studies of the DNA−Topoisomerase I Ternary Cleavable Complex with Camptothecin
1998 StandoutNobel
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Estrogen Metabolite 2-Methoxyestradiol Induces Apoptosis and Inhibits Cell Proliferation and Collagen Production in Rat and Human Leiomyoma Cells: A Potential Medicinal Treatment for Uterine Fibroids
2006 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Evaluation of the Delivery and Safety of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Pulmonary Malignancies
2004
Natural and Designed Proteins Inspired by Extremotolerant Organisms Can Form Condensates and Attenuate Apoptosis in Human Cells
2022 StandoutNobel
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer
2012
Mathematics – Key Technology for the Future
2008 Standout
Multi-Institutional Study of the Angiogenesis Inhibitor TNP-470 in Metastatic Renal Carcinoma
1999
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
2017
Biomedical Importance of Indoles
2013 Standout
Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents
2003
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Works of M Steger being referenced
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer
1999
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
1997
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
1997
Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma
2000